Algernon Pharmaceuticals CEO Christopher Moreau to present at Proactive’s One2One Virtual Investor Conference to be held December 8, 2020
Algernon Pharmaceuticals Inc. (CSE:AGN) (OTCQB:AGNPF) CEO Christopher Moreau discusses with Christine Corrado of Proactive that he will be one of three emerging companies to present at Proactive’s One2One Virtual Investor Conference on Tuesday, December 8, at 1:30PM.
Mr. Moreau offered investors a highlight on what he’s expected to speak on next week. To register for this free event, please click below.
